Using the XeriSol Formulation Platform for Peptide Parenteral Drug Delivery
1:30 pm - Thursday 30th April 2026
- Presenting a non-aqueous, high concentration subcutaneous solution
- Enabling room temperature stability
- Showcasing excellent safety and toxicity profiles
NEW COMPANY
